Brazil was the last country to enter the fiscal crisis, but also the first to exit. And with a burgeoning middle class and a staunch commitment to national development, its pharmaceutical future is now.
Brazil's clinical trial research is the country's backbone.
Biominas helps foster the development of biotech-related businesses in Brazil.
Astellas makes its presence felt in Brazil.
French-based Besins is a relatively new entrant to the Brazilian pharma market.
Torrent's affiliate in Brazil has become the India-based company's biggest.
Brazilian industry is learning to spread its pharma manufacturing around more.
The use and study of DDW by the Hungarian medical community
A quick chat with CMO of Assign Group Dr. Kata Mazalin
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial